Aventus Thrombectomy System Pulmonary Embolism Clinical Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 120 participants.

Also called NCT05907564

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Inquis Medical, Inc. (from the registry)
Registry
  • NCT NCT05907564
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05907564. Allocation not applicable; no masking; primary purpose treatment. Start 2023-09-20 (actual); primary completion 2025-02-20 (actual). Results posted on 2026-09-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
Condition
Embolism
Condition
Embolism and Thrombosis
Condition
Vascular Diseases
Condition
Cardiovascular Diseases
Condition
Lung Diseases
Condition
Respiratory Tract Diseases
Intervention (Device)
Thrombectomy
Lead sponsor
Inquis Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05907564
Content hash
a018624b222eb001a3626a1a2a58bcfa31358a02645bcf74eb8728de71ae881d